Company / Gross Profit per Share
PLUS THERAPEUTICS, INC. Gross Profit per Share History
FY2011-FY2017 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Profit per Share
$0.01
FY2017
5-year range
$0.01 / $0.13
FY2013-FY2017
Trend
-92.4%
vs FY2016
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Gross Profit per Share has fluctuated over the past 7 years, ranging from $0.01 in FY2017 to $0.13 in FY2016.
Based on SEC 10-K filings.
0.01 in FY2017 with a 5-year CAGR of -33.9%.
Declined from $0.04 to $0.01 over the past 2 years.
Gross Profit per Share over time
Growth rates
- 3-Year CAGR
- -47.2%
- 5-Year CAGR
- -33.9%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2017, gross profit per share decreased 92.4% year-over-year.
- Peak gross profit per share was recorded in FY2016.
Company context
Key Data Points
- Altman Z-Score -2.46 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross Profit per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2018 | - | - |
| FY2017 | $0.01 | -92.4% |
| FY2016 | $0.13 | +241.0% |
| FY2015 | $0.04 | -43.6% |
| FY2014 | $0.07 | +5.0% |
| FY2013 | $0.06 | -18.1% |
| FY2012 | $0.08 | +63.3% |
| FY2011 | $0.05 | - |
As of FY2017 · SEC 10-K · Updated Jun 28, 2026